CSF beta‐amyloid 1–42 – what are we measuring in Alzheimer's disease?
نویسندگان
چکیده
منابع مشابه
CSF beta-amyloid 1–42 – what are we measuring in Alzheimer's disease?
OBJECTIVE To characterize biological and technical factors which influence cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarker levels, including the presence of apolipoprotein E (APOE) ε4 allele, AD diagnosis, Aβ-binding proteins, sample processing, and preanalytical handling. METHODS CSF was collected from 140 subjects with normal cognition, mild cognitive impairment, AD, and non-AD...
متن کاملRotten Apples or Bad Harvest? What We Are Measuring When We Are Measuring Abuse
Internet security and technology policy research regularly uses technical indicators of abuse in order to identify culprits and to tailor mitigation strategies. As a major obstacle, readily available data are often misaligned with actual information needs. They are subject to measurement errors relating to observation, aggregation, attribution, and various sources of heterogeneity. More precise...
متن کاملWhat Are We Measuring When We Evaluate Journals?
This article undertakes two studies to examine issues related to journal rankings. Study 1 examines the consistency between journal rankings reported in past studies. It finds that while there is consistency when comparing these studies, this consistency does not always occur outside the top-ranked journals. Study 2 explores whether individuals believe that the weighting of four underlying eval...
متن کاملOutcomes assessment in rotator cuff pathology: what are we measuring?
BACKGROUND Assessments used to measure outcomes associated with rotator cuff pathology and after repair are varied. This lack of standardization leads to difficulty drawing comparisons across studies. We hypothesize that this variability in patient-reported outcome measures and objective metrics used in rotator cuff studies persists even in high-impact, peer reviewed journals. METHODS All stu...
متن کاملVisual perception in preterm children: what are we currently measuring?
Over the past two decades, cerebral visual impairment has been recognized as a principal deficit in preterm children, and in particular those with cerebral palsy. We review the current knowledge of visual processing deficits in these children, and provide an overview of the tools for assessing cerebral visual impairment. Commercially available instruments are usually directed at evaluating visu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Clinical and Translational Neurology
سال: 2014
ISSN: 2328-9503,2328-9503
DOI: 10.1002/acn3.160